{
    "SPADE_N_13739": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_N_13739",
            "Peptide Name": "Bogorol K (natural AMPs; nonribosomal peptide; bogorol family, lipopeptide, XXL; XXW1, XXD2; Val-rich; BBMm; bacteria, prokaryotes; Derivatives: Succilin K, XX1)",
            "Source": "Brevibacillus laterosporusMG64",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "TVRIIVKVVKYLV",
            "Sequence Length": 13,
            "UniProt Entry": "Ref",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-"
            ],
            "Target Organism": "Not found",
            "Hemolytic Activity": "Not found",
            "Cytotoxicity": "Not found",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Not found",
            "N-terminal Modification": "Not found",
            "C-terminal Modification": "Not found",
            "Stereochemistry": "Not found",
            "Structure Description": "Not found",
            "Formula": "Not found",
            "Mass": 1529.95,
            "PI": 10.29,
            "Hydrophobicity": 1.5,
            "Half Life": "Not found",
            "Function": "Not found",
            "Literature": [
                {
                    "Author": "Li Z, de Vries RH, Chakraborty P, Song C, Zhao X, Scheffers DJ, Roelfes G, Kuipers OP. 2020",
                    "Reference": "Appl Environ Microbiol. 2020 Nov 24;86(24):e01981-20. doi: 10.1128/AEM.01981-20.PubMed",
                    "Title": "Novel Modifications of Nonribosomal Peptides from Brevibacillus laterosporus MG64 and Investigation of Their Mode of Action."
                }
            ],
            "Frequent Amino Acids": "VIK",
            "Absent Amino Acids": "ACDEFGHMNOPQSUW",
            "Basic Residues": 3,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 9,
            "Polar Residues": 10,
            "Positive Residues": 3,
            "Negative Residues": 0,
            "Net Charge": 3,
            "Comments": "Sequence analysis: APD analysis reveals this sequence is most similar (46.67%) toPd_mastoparan PDD-AV: 38%.Chemical modification: T1 dehydrated (Dhb); R3=ornithine; N-terminus is acylated with 2-hydroxy-3-methylvaleric acid (lipo), the lipoinitiation of bogorols is mediated by the module encoded by bogJ.; In addition, R3 is a D-aa and also succinylated! Y11 is also a D-aa;Activity:  active against X. campestris pv. campestris NCCB92058 (MIC 4 ug/ml), X. translucens pv. graminis LMG587 (MIC 8 ug/ml), P. syringae pv. antirrhini LMG2131, P. syringae pv. tomato DC3000 (MIC 16 ug/ml), P. aeruginosa PAO1 (MIC 32 ug/ml), K. pneumoniae LMG20218 (MIC 16 ug/ml), E. coli ET8 or MG1665 (MIC 8-16 ug/ml),  P-carotovorum LMG5863 (MIC>32  ug/ml), R-syzygii subsp. syzygii LMG6969 (MIC >32  ug/ml), S. aureus subsp. aureus 533 R4, B. cereus ATCC 14579 (MIC 2  ug/ml), E. faecium LMG16003 (MIC 4  ug/ml).MOA:  It penetrates bacterial outer and inner membranes.SAR:  the activity of Bogorol K may be regulated by succinylation of O3, leading to Succilin K. Succinylation decreases the peptide activity due to the conversion of a basic amino acid into an acidic aa. As a consequence, Succilin K cannot penetrate bacterial outer and inner membranes.",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_13740",
                    "Similarity": 0.9230769230769231,
                    "Sequence": "TVKIIVKVVKYLV"
                },
                {
                    "SPADE_ID": "SPADE_N_15517",
                    "Similarity": 0.9090909090909091,
                    "Sequence": "VKIIVKVVKYL"
                },
                {
                    "SPADE_ID": "SPADE_N_15008",
                    "Similarity": 0.9,
                    "Sequence": "LIIVKVVKYL"
                }
            ]
        }
    }
}